Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis

Area of Science:

• Global Health
• Nanomedicine
• Pharmacology

Background:

• HIV remains a significant global health challenge, with millions living with the virus and new infections reported annually.
• Current pre-exposure prophylaxis (PrEP) methods face limitations, particularly for women in high-risk regions like sub-Saharan Africa, due to social, adherence, and drug-related barriers.
• Antiretroviral drugs (ARVs) used in PrEP are essential but face challenges in efficacy and delivery.

Purpose of the Study:

• To review advancements in nanotechnology for improved HIV PrEP.
• To summarize comparative studies of nanoparticle-encapsulated ARVs versus traditional drug solutions.
• To explore novel delivery systems for nanoparticle-based PrEP.

Main Methods:

• Review of in vitro studies comparing nanoparticle-encapsulated ARVs with drug solutions.
• Evaluation of nanotechnology's potential for enhanced drug release and bioavailability.
• Analysis of delivery systems like thermosensitive gels and nanoparticle films for direct prophylactic application.

Main Results:

• Nanoparticle encapsulation of ARVs demonstrates higher efficacy and lower cytotoxicity compared to conventional drug solutions in vitro.
• Nanotechnology offers potential for extended drug release and improved bioavailability of ARVs.
• Specific delivery systems can facilitate targeted administration of nano-encapsulated ARVs to relevant tissues.

Conclusions:

• Nanotechnology presents a promising approach to overcome current limitations in HIV PrEP.
• Nanoparticle-based ARV delivery systems can enhance efficacy and address bioavailability challenges.
• Thermosensitive gels and nanoparticle films are potential delivery methods for effective nano-PrEP applications.